The following should be read in conjunction with "Cautionary Statement
Regarding Forward Looking Statements" and our combined consolidated financial
statements and notes thereto included in Item 15 of this Annual Report on Form
10-K.
Operating Results
Factors Affecting Operating Results
  Bunge Limited, a Bermuda company, together with its subsidiaries, is a leading
global agribusiness and food company with integrated operations that stretch
from farmer to consumer. The commodity nature of the Company's principal
products, as well as regional and global supply and demand variations that occur
as an inherent part of the business, make volumes an important operating
measure. Accordingly, information is included in "Segment Results" that
summarizes certain items in our consolidated statements of income and volumes by
reportable segment. The common unit of measure for all reported volumes is
metric tons. A description of reported volumes for each reportable segment has
also been included in the discussion of key factors affecting results of
operations in each of our business segments as discussed below.
Agribusiness
  In the Agribusiness segment, we purchase, store, transport, process and sell
agricultural commodities and commodity products. Profitability in this segment
is affected by the availability and market prices of agricultural commodities
and processed commodity products and the availability and costs of energy,
transportation and logistics services. Profitability in our oilseed processing
operations is also impacted by volumes procured, processed and sold and by
capacity utilization rates. Availability of agricultural commodities is affected
by many factors, including weather, farmer planting and selling decisions, plant
diseases, governmental policies, and agricultural sector economic conditions.
Reported volumes in this segment primarily reflect (i) grains and oilseeds
originated from farmers, cooperatives or other aggregators and from which
"origination margins" are earned; (ii) oilseeds processed in our oilseed
processing facilities and from which "crushing margins" are earned, representing
the margin from the industrial separation of the oilseed into its protein meal
and vegetable oil components, both of which are separate commodity products; and
(iii) third party sales of grains, oilseeds and related commodity products
merchandised through our distribution businesses and from which "distribution
margins" are earned. The foregoing subsegment volumes may overlap as they
produce separate margin capture opportunities. For example, oilseeds procured in
our
South American grain origination activities may be processed in our oilseed
processing facilities in Asia-Pacific and will be reflected at both points
within the segment. As such, these reported volumes do not represent solely
volumes of net sales to third-parties, but rather where margin is earned,
appropriately reflecting their contribution to our global network's capacity
utilization and profitability.

  Demand for our purchased and processed Agribusiness products is affected by
many factors, including global and regional economic conditions, changes in per
capita income, the financial condition of customers and customer access to
credit, worldwide consumption of food products, particularly pork and poultry,
population growth rates, relative prices of substitute agricultural products,
outbreaks of disease associated with livestock and poultry, and demand for
renewable fuels produced from agricultural commodities and commodity products.

  We expect that the factors described above will continue to affect global
supply and demand for our Agribusiness products for the foreseeable future. We
also expect that, from time to time, imbalances will likely exist between
oilseed processing capacity and demand for oilseed products in certain regions,
which impacts our decisions regarding whether, when and where to purchase,
store, transport, process or sell these commodities, including whether to change
the location of or adjust our own oilseed processing capacity.

  Additionally, price fluctuations and availability of commodities may cause
fluctuations in our working capital, such as inventories, accounts receivable
and borrowings over the course of a given year. For example, increased
availability of commodities at harvest times often causes fluctuations in our
inventories and borrowings. Increases in agricultural commodity prices will also
generally cause our cash flow requirements to increase as our operations require
increased use of cash to acquire inventories and fund daily settlement
requirements on exchange traded futures that we use to hedge our physical
inventories.
Edible Oils and Milling
  In Edible Oil Products and Milling Products segments, our operating results
are affected by changes in the prices of raw materials, such as crude vegetable
oils and grains, the mix of products that we sell, changes in consumer eating
habits, changes in per capita income, consumer purchasing power levels,
availability of credit to customers, governmental dietary guidelines and
policies, changes in regional economic conditions and the general competitive
environment in our markets. Raw material inputs to our production processes in
the Edible Oil Products and Milling Products segments are largely sourced at
                                       27

--------------------------------------------------------------------------------

Table of Contents



market prices from our Agribusiness segment. Reported volumes in these segments
reflect third-party sales of our finished products and, as such, include the
sales of products derived from raw materials sourced from the Agribusiness
segment as well as from third-parties. The unit of measure for these volumes is
metric tons as these businesses are linked to the commodity raw materials, which
are their primary inputs.
Fertilizer
  In the Fertilizer segment, demand for our products is affected by the
profitability of the agricultural sectors we serve, the availability of credit
to farmers, agricultural commodity prices, the types of crops planted, the
number of acres planted, the quality of the land under cultivation and
weather-related issues affecting the success of the harvests. Our profitability
is impacted by international selling prices for fertilizers and fertilizer raw
materials, such as phosphate, sulfur, ammonia and urea, ocean freight rates and
other import costs, as well as import volumes at the port facilities we manage.
As our operations are in South America, primarily Argentina, our results in this
segment are typically seasonal, with fertilizer sales normally concentrated in
the third and fourth quarters of the year due to the timing of the South
American agricultural cycle. Reported volumes in this segment reflect
third-party sales of our finished products.
Sugar and Bioenergy
  Our Sugar and Bioenergy segment primarily comprises our 50% interest in BP
Bunge Bioenergia, the joint venture formed in December 2019 by the combination
of our Brazilian sugar and bioenergy operations with the Brazilian biofuels
business of BP. Our Brazilian sugar and bioenergy operations formed the majority
of our Sugar and Bioenergy segment through which we produced and sold sugar and
ethanol derived from sugarcane, as well as energy derived from the sugar and
ethanol production process. BP Bunge Bioenergia operates on a stand-alone basis
with a total of 11 mills located across the Southeast, North and Midwest regions
of Brazil. BP Bunge Bioenergia is now the second largest operator by effective
crushing capacity in the Brazilian sugarcane ethanol biofuel industry. As a
result of this transaction, we no longer consolidate our Brazilian sugar and
bioenergy operations in our consolidated financial statements and instead
account for our interest in the joint venture under the equity method of
accounting. Accordingly, our reported Sugar and Bioenergy results for 2020
include our share of the net earnings in BP Bunge Bioenergia, whereas our Sugar
and Bioenergy results for 2019 reflect our former 100% ownership interest in the
Brazilian sugar and bioenergy operations contributed to the Joint Venture.
Although we are committed to supporting the growth and development of BP Bunge
Bioenergia, our long-term goal is to seek strategic opportunities for our
investment in the joint venture.
Profitability in this segment is affected by the profitability of the joint
venture and, therefore the value of our investment and the amount and timing of
distributions we receive, if any. In turn, the profitability of the joint
venture is affected by the availability and quality of sugarcane, which impacts
capacity utilization rates and the amount of sugar that can be extracted from
the sugarcane, and by market prices of sugar and ethanol. The availability and
quality of sugarcane is affected by many factors, including weather,
geographical factors such as soil quality and topography, and agricultural
practices. Once planted, sugarcane may be harvested for several continuous
years, but the yield decreases with each subsequent harvest. As a result, the
current optimum economic cycle is generally five to seven consecutive harvests,
depending on location. The joint venture owns and/or has partnership agreements
to manage farmland on which it grows and harvests sugarcane and also purchases
sugarcane from third parties. Prices of sugarcane in Brazil are established by
Consecana, the state of São Paulo sugarcane, sugar and ethanol council, and are
based on the sucrose content of the cane and the market prices of sugar and
ethanol. Demand for the joint venture's products is affected by such factors as
changes in global or regional economic conditions, the financial condition of
customers and customer access to credit, worldwide consumption of food products,
population growth rates, changes in per capita income and demand for and
governmental support of renewable fuels produced from agricultural commodities,
including sugarcane.
  In addition to these industry related factors which impact our business areas,
our results of operations in all business areas and segments are affected by the
following factors:
Foreign Currency Exchange Rates
  Due to the global nature of our operations, our operating results can be
materially impacted by foreign currency exchange rates. Both translation of our
foreign subsidiaries' financial statements and foreign currency transactions can
affect our results. On a monthly basis, for subsidiaries whose functional
currency is a currency other than the U.S. dollar, subsidiary statements of
income and cash flows must be translated into U.S. dollars for consolidation
purposes based on weighted-average exchange rates in each monthly period. As a
result, fluctuations of local currencies compared to the U.S. dollar during each
monthly period impact our consolidated statements of income and cash flows for
each reported period (per quarter and year-to-date) and also affect comparisons
between those reported periods. Subsidiary balance sheets are translated using
exchange rates as of the balance sheet date with the resulting translation
adjustments reported in our consolidated balance sheets as a component of
Accumulated other comprehensive income (loss).
                                       28

--------------------------------------------------------------------------------

Table of Contents



  Additionally, we record transaction gains or losses on monetary assets and
liabilities that are not denominated in the functional currency of the entity.
These amounts are remeasured into their respective functional currencies at
exchange rates as of the balance sheet date, with the resulting gains or losses
included in the entity's statement of income and, therefore, in our consolidated
statements of income as Foreign exchange gains (losses).
  We primarily use a combination of equity and intercompany loans to finance our
subsidiaries. Intercompany loans that are of a long-term investment nature with
no intention of repayment in the foreseeable future are considered permanently
invested and as such are treated as analogous to equity for accounting purposes.
As a result, any foreign currency translation gains or losses on such
permanently invested intercompany loans are reported in Accumulated other
comprehensive income (loss) in our consolidated balance sheets. In contrast,
foreign currency translation gains or losses on intercompany loans that are not
of a permanent nature are recorded in our consolidated statements of income as
Foreign exchange gains (losses).
Income Taxes
  As a Bermuda exempted company, we are not subject to income taxes on income in
our jurisdiction of incorporation.  However, our subsidiaries, which operate in
multiple tax jurisdictions, are subject to income taxes at various statutory
rates ranging from 0% to 34%. The jurisdictions that significantly impact our
effective tax rate are Brazil, the United States, Argentina and Bermuda.
Determination of taxable income requires the interpretation of related and often
complex tax laws and regulations in each jurisdiction in which we operate, and
the use of estimates and assumptions regarding future events.
Non-U.S. GAAP Financial Measures
  Total segment earnings before interest and taxes ("EBIT") is an operating
performance measure used by our management to evaluate segment operating
activities. Our management believes total segment EBIT is a useful measure of
operating profitability, since the measure allows for an evaluation of the
performance of its segments without regard to its financing methods or capital
structure. In addition, EBIT is a financial measure that is widely used by
analysts and investors in our industries. Total Segment EBIT is a non-U.S. GAAP
financial measure and is not intended to replace Net income (loss) attributable
to Bunge, the most directly comparable U.S. GAAP financial measure.
Cash provided by (used for) operating activities, adjusted is calculated by
including the Proceeds from beneficial interested in securitized trade
receivables with Cash provided by (used for) operating activities. Cash provided
by (used for) operating activities, adjusted is a non-GAAP financial measure and
is not intended to replace Cash provided by (used for) operating activities, the
most directly comparable U.S. GAAP financial measure. Our management believes
presentation of this measure allows investors to view our cash generating
performance using the same measure that management uses in evaluating financial
and business performance and trends.

2020 Overview
Net Income (Loss) Attributable to Bunge - For the year ended December 31, 2020,
net income attributable to Bunge was $1,145 million, an increase of $2,425
million compared to a net loss attributable to Bunge of $1,280 million for the
year ended December 31, 2019. The increase is due to higher Segment EBIT in our
Core and Non-core segments, as further discussed in the Segment Overview and
Results of Operations section below.
Earnings Per Common Share - Diluted - For the year ended December 31, 2020, net
income attributable to Bunge common shareholders, diluted, was $7.71 per share,
an increase of $17.05 per share, compared to a loss of $9.34 per share for the
year ended December 31, 2019.
EBIT - For the year ended December 31, 2020, Total Segment EBIT was $1,633
million, an increase of $2,524 million compared to EBIT of $(891) million for
the year ended December 31, 2019. The increase in Total Segment EBIT for the
year ended December 31, 2020 was due to higher Segment EBIT in our Core and
Non-core segments, as further discussed in the Segment Overview and Results of
Operations section below, which provides a reconciliation of net income (loss)
attributable to Bunge to Total Segment EBIT.
Income Tax (Expense) Benefit - Income tax expense was $248 million for the year
ended December 31, 2020 compared to income tax expense of $86 million for the
year ended December 31, 2019. The increase in income tax expense for the year
ended December 31, 2020 was primarily due to higher pretax income, resulting
from higher EBIT in our Core and Non-core segments, as noted above.
                                       29

--------------------------------------------------------------------------------

Table of Contents



Liquidity and Capital Resources - At December 31, 2020, working capital, which
equals total current assets less total current liabilities, was $5,196 million,
an increase of $1,543 million, compared to working capital of $3,653 million at
December 31, 2019. The increase in working capital is primarily due to increased
readily marketable inventories ("RMI") purchases associated with strong farmer
selling activity in Brazil during the twelve months ended December 31, 2020 as
well as higher commodity prices at December 31, 2020.
Segment Overview and Results of Operations
Our operations are organized, managed and classified into five reportable
segments based upon their similar economic characteristics, nature of products
and services offered, production processes, types and classes of customer, and
distribution methods.
We further organize these reportable segments into Core operations and Non-core
operations. Core operations comprise our Agribusiness, Edible Oil Products,
Milling Products, and Fertilizer segments.
Non-core operations comprise our Sugar and Bioenergy segment, which itself
primarily comprises our 50% interest in BP Bunge Bioenergia, a joint venture
formed with BP in December 2019 by the combination of our Brazilian sugar and
bioenergy operations with the Brazilian biofuels business of BP. Therefore, our
reported Sugar and Bioenergy results for 2020 include our share of the net
earnings in BP Bunge Bioenergia, whereas our Sugar and Bioenergy results for
2019 reflect our former 100% ownership interest in the Brazilian sugar and
bioenergy operations contributed to the joint venture.
Our remaining operations are not reportable segments, as defined by the
applicable accounting standard, and are classified as Corporate and Other.
Effective January 1, 2020, we changed our segment reporting to separately
disclose Corporate and Other activities from our reporting segments, as further
described in Note 28- Segment Information. Certain reclassifications of prior
period amounts within the reporting segments have been made to conform to
current presentation.
A reconciliation of Net income (loss) attributable to Bunge to Total Segment
EBIT follows:
                                                                          Year Ended
                                                                         December 31,
  (US$ in millions)                                             2020          2019         2018
  Net income (loss) attributable to Bunge                     $ 1,145      $ (1,280)     $  267
  Interest income                                                 (22)          (31)        (31)
  Interest expense                                                265           339         339
  Income tax expense                                              248            86         179
  (Income) loss from discontinued operations, net of tax            -       

- (10)


  Noncontrolling interests' share of interest and tax              (3)      

(5) (7)


  Total segment EBIT                                          $ 1,633

$ (891) $ 737


  Agribusiness Segment EBIT                                     1,482       

682 848


  Edible Oil Products Segment EBIT                                440       

121 174


  Milling Products Segment EBIT                                    78            88         114
  Fertilizer Segment EBIT                                          85            62          46
  Core Segment EBIT                                             2,085           953       1,182
  Corporate and Other EBIT                                       (365)         (245)       (342)
  Sugar & Bioenergy Segment EBIT                                  (87)       (1,599)       (103)
  Non-core Segment EBIT                                           (87)       (1,599)       (103)
  Total Segment EBIT                                          $ 1,633      $   (891)     $  737



                                       30

--------------------------------------------------------------------------------


  Table of Contents

Core Segments
Agribusiness Segment
                                                                 Year Ended
                                                                December 31,
(US$ in millions)                                     2020          2019          2018
Volumes (in thousand metric tons)                   142,959       139,968       146,309
Net sales                                          $ 29,529      $ 28,407      $ 32,206
Cost of goods sold                                  (27,749)      (27,314)      (30,759)
Gross profit                                          1,780         1,093         1,447
Selling, general and administrative expense            (517)         (487)  

(531)


Foreign exchange gains (losses)                         148           (34)  

(122)


EBIT attributable to noncontrolling interests           (18)            2           (14)
Other income (expense) - net                             43            65            41
Income (loss) from affiliates                            46            43            27
Total Agribusiness Segment EBIT                    $  1,482      $    682      $    848



2020 Compared to 2019
Agribusiness segment Net sales increased by $1,122 million, or 4%, to $29,529
million for the year ended December 31, 2020, compared to $28,407 million for
the year ended December 31, 2019. The net increase was due to the following:
•In Oilseeds, Net sales increased $1,586 million primarily due to higher soybean
sales volumes and prices in our Chinese, Brazilian, European, and North American
oilseed processing businesses, primarily driven by increased meal demand in
China and increased oil demand in North America, higher sales volumes and prices
in our European and Canadian oilseed processing businesses, and higher sales
prices in our global oilseed trading and distribution businesses, partially
offset by lower overall trading and distribution volumes.
•In Grains, Net sales decreased $464 million due to lower sales volumes and
prices in our grain trading and distribution businesses, lower sales volumes and
prices in our European grain origination business, and lower sales prices in our
Brazilian origination business. These decreases were partially offset by higher
volumes in our Brazilian grain origination business driven by increased farmer
selling in response to depreciation of Brazilian real versus the U.S. dollar
earlier in the year, and higher volumes in our North American grain origination
business driven by increased demand from China following an easing of trade
restrictions in place for much of the prior year.
Cost of goods sold increased by $435 million, or approximately 2%, to $27,749
million for the year ended December 31, 2020 compared to $27,314 million for the
year ended December 31, 2019. The net increase was primarily due to the
following:
•In Oilseeds, Cost of goods sold increased by $1,242 million due to higher Net
sales in our oilseed processing and trading and distribution businesses, as
described above, as well as unfavorable mark-to-market results in our oilseed
processing businesses, partially offset by favorable translation impacts on
industrial costs, as most currencies in which such expenses are denominated
depreciated versus the U.S. dollar during the year, and non-recurring prior year
property, plant and equipment (PP&E) impairment charges at various facilities
associated with portfolio rationalization initiatives.
•In Grains, Cost of goods sold decreased by $807 million due to the decrease in
Net sales noted above, risk management and optimization in our trading and
distribution businesses, favorable translation impacts on industrial costs as
most currencies in which such expenses are denominated depreciated versus the
U.S. dollar during the year, and non-recurring prior year PP&E impairment
charges at various facilities associated with portfolio rationalization
initiatives.
Gross profit increased by $687 million, or 63%, to $1,780 million for the year
ended December 31, 2020, compared to $1,093 million for the year ended
December 31, 2019. The increase was primarily due to the following:
                                       31

--------------------------------------------------------------------------------

Table of Contents



•In Oilseeds, an increase of $344 million was due to higher Net sales in excess
of Cost of goods sold, as described above.
•In Grains, an increase of $343 million was due to lower Cost of goods sold,
which more than offset lower Net sales, primarily in our North American
operations as described above.
SG&A expenses increased $30 million, or 6%, to $517 million for the year ended
December 31, 2020, compared to $487 million for the year ended December 31,
2019. The increase was mainly due to higher variable incentive costs on the back
of improved overall company profitability, partially offset by savings
associated with ongoing cost initiatives, lower expenses due to COVID-19 travel
restrictions, favorable translation impacts, as most currencies in which SG&A
expenses are denominated depreciated versus the U.S. dollar during the year, and
an $11 million prior year write-off of an indemnification asset associated with
the reversal of an uncertain tax position.
Foreign exchange results increased $182 million, to a gain of $148 million for
the year ended December 31, 2020, compared to a loss of $34 million for the year
ended December 31, 2019. Foreign exchange results were primarily driven by gains
on U.S. dollar denominated loans receivable in non-U.S. functional currency
operations.
Other income (expenses) - net decreased $22 million, to income of $43 million
for the year ended December 31, 2020, compared to income of $65 million for the
year ended December 31, 2019. The decrease was primarily due to lower results
from our financial services activities during the current year.
Segment EBIT increased $800 million, or 117%, to $1,482 million for the year
ended December 31, 2020, compared to $682 million for the year ended
December 31, 2019. The increase was primarily due to the following:
•In Oilseeds, an increase of $440 million was primarily due to higher Gross
profit and increased foreign exchange results, as described above.
•In Grains, an increase of $360 million was primarily due to higher Gross profit
and increased foreign exchange results as described above.
2019 Compared to 2018
Agribusiness segment Net sales decreased by $3,799 million, or 12%, to $28,407
million for the year ended December 31, 2019, compared to $32,206 million for
the year ended December 31, 2018. The net decrease was due to the following:
•In Oilseeds, Net sales decreased $1,979 million due to lower average sales
prices following increased global soybean meal availability due to increased
Argentinian supply compared to the 2018 drought and limited harvest, coupled
with lower Chinese demand as a result of the African Swine Fever outbreak.
•In Grains, Net sales decreased $1,820 million due to lower sales volumes in our
grain origination, trading and distribution businesses, associated with lower
supply in North America due to adverse weather conditions and the ongoing
US-China trade dispute, and lower farmer selling in Brazil through much of 2019.
Cost of goods sold decreased by $3,445 million, or 11%, to $27,314 million for
the year ended December 31, 2019, compared to $30,759 million for the year ended
December 31, 2018. The net decrease was primarily due to the following:
•In Oilseeds, Cost of goods sold decreased by $1,669 million due to lower
purchase prices and improved trading results in our oilseed businesses,
partially offset by unfavorable mark-to-market results in our oilseed processing
business, and approximately $87 million of impairment charges related to PP&E at
various facilities associated with portfolio rationalization initiatives.
•In Grains, Cost of goods sold decreased by $1,776 million due to lower sales
volumes and purchase prices in our grain origination, trading and distribution
businesses, partially offset by stronger results in our ocean freight business.
Gross profit decreased by $354 million, or 24%, to $1,093 million for the year
ended December 31, 2019, compared to $1,447 million for the year ended
December 31, 2018. The net decrease was primarily due to the following:
•In Oilseeds, a decrease of $310 million was due to lower Net sales in excess of
lower Cost of goods sold, as described above.
•In Grains, a decrease of $44 million was due to lower Net sales in excess of
lower Cost of goods sold, as described above.
                                       32

--------------------------------------------------------------------------------

Table of Contents



SG&A expenses decreased $44 million, or 8%, to $487 million for the year ended
December 31, 2019, compared to $531 million for the year ended December 31,
2018. The decrease was mainly due to savings from actions associated with the
Global Competitiveness Program ("GCP"), as well as lower charges recognized in
connection with the execution of the GCP itself, in addition to depreciation of
the Brazilian real against the U.S. dollar. These decreases were partially
offset by impairment charges at facilities associated with portfolio
rationalization initiatives and the write-off of a tax indemnification asset
associated with the reversal of an uncertain tax position recorded in a previous
year.
Foreign exchange gains (losses), on a net basis, increased $88 million, or 72%,
to a loss of $34 million for the year ended December 31, 2019, compared to a
loss of $122 million for the year ended December 31, 2018. Foreign exchange
results are primarily driven by funding non-U.S. functional currency operations.
Results in 2018 were primarily driven by the devaluation of the Argentine peso
on U.S. dollar loans to fund operations in Argentina.
Other income (expenses) - net increased $24 million, to income of $65 million
for the year ended December 31, 2019, compared to income of $41 million for the
year ended December 31, 2018. The increase was primarily due to higher income
earned from financial services activities and improved results from our soy
crush investments in South America.
Segment EBIT decreased $166 million, or 20%, to $682 million for the year ended
December 31, 2019, compared to $848 million for the year ended December 31,
2018. The net decrease was primarily due to the following:
•In Oilseeds, a decrease of $252 million was primarily due to lower profits in
our oilseed processing business, including an unfavorable mark-to-market impact
on forward contracts compared to the prior year.
•In Grains, an increase of $86 million was primarily due higher results in our
ocean freight business, better results in our financial services businesses,
lower SG&A expenses, and higher net foreign exchange results, partially offset
by lower profits in our grain origination, trading and distribution businesses.
Edible Oil Products Segment
                                                               Year Ended
                                                              December 31,
(US$ in millions)                                    2020         2019      

2018


Volumes (in thousand metric tons)                    9,515        9,606        9,024
Net sales                                          $ 9,601      $ 9,186      $ 9,129
Cost of goods sold                                  (8,863)      (8,574)      (8,571)
Gross profit                                           738          612          558
Selling, general and administrative expense           (388)        (376)    

(348)


Foreign exchange gains (losses)                         (2)          (1)    

(1)


EBIT attributable to noncontrolling interests           (3)           7     

(12)


Other income (expense) - net                            95         (121)    

(23)



Total Edible Oils Products Segment EBIT            $   440      $   121      $   174



2020 Compared to 2019
Edible oil products segment Net sales increased by $415 million, or 5%, to
$9,601 million for the year ended December 31, 2020, compared to $9,186 million
for the year ended December 31, 2019, due to higher sales volumes and prices in
our business-to-consumer ("B2C") operations, driven by increased at-home
consumption associated with COVID-19 stay-at-home orders, and higher prices in
our business-to-business ("B2B") operations, partially offset by lower overall
B2B volumes as lower food services volumes more than offset higher food
processor volumes, again due to COVID-19. The year ended December 31, 2020 also
benefited from $47 million of indirect tax credits related to the favorable
resolution of a Brazilian indirect tax claim.
Cost of goods sold increased by $289 million, or 3%, to $8,863 million for the
year ended December 31, 2020, compared to $8,574 million for the year ended
December 31, 2019. The increase in Cost of goods sold was due to higher Net
sales, partially offset by favorable translation impacts, unfavorable prior year
mark-to-market results, and approximately $30 million of non-recurring prior
year PP&E impairment charges at various facilities associated with portfolio
rationalization initiatives.
Gross profit increased by $126 million, or 21%, to $738 million for the year
ended December 31, 2020, compared to $612 million for the year ended
December 31, 2019. The increase was primarily due to higher Net sales in excess
of Cost of
                                       33

--------------------------------------------------------------------------------

Table of Contents



goods sold, primarily related to our consumer business margin expansion
resulting from COVID-19 related supply shortage, as described above.
SG&A expenses increased $12 million, or 3%, to $388 million for the year ended
December 31, 2020, compared to $376 million for the year ended December 31,
2019. The increase was primarily due to higher variable incentive costs on the
back of improved overall company profitability, increased bad debt expense,
partially offset by favorable translation impacts and lower travel costs
associated with COVID-19 travel restrictions.
EBIT attributable to noncontrolling interests, an expense when subsidiaries with
noncontrolling interests generate earnings before interest and tax, versus
income when subsidiaries with noncontrolling interests generate loss before
interest and tax, decreased by $10 million, to expense of $3 million for the
year ended December 31, 2020, compared to income of $7 million for the year
ended December 31, 2019. The decrease was primarily due to earnings before
interest and tax associated with our non-wholly-owned Edible Oil Products
subsidiaries, primarily Loders, for the year ended December 31, 2020, compared
to losses before interest and tax in the same businesses for the year ended
December 31, 2019, in both years primarily driven by factors mentioned above.
Other income (expenses) - net increased $216 million to income of $95 million
for the year ended December 31, 2020 compared to expense of $121 million for the
year ended December 31, 2019, due to a gain on the sale of our Brazilian
margarine and mayonnaise assets, which closed in the fourth quarter of 2020, and
a non-recurring prior year goodwill impairment charge of $108 million associated
with Loders.
Segment EBIT increased by $319 million, or 264%, to $440 million for the year
ended December 31, 2020, compared to $121 million for the year ended
December 31, 2019. The increase was primarily due to higher Gross profit and
Other income (expenses) - net, as described above.
2019 Compared to 2018
Edible oil products segment Net sales increased by $57 million, or 1%, to $9,186
million for the year ended December 31, 2019, compared to $9,129 million for the
year ended December 31, 2018. Increased sales volumes driven by our acquisition
of Loders on March 1, 2018, were offset by lower prices in the U.S., Europe, and
Brazil.
Cost of goods sold increased slightly by $3 million, or zero percent, to $8,574
million for the year ended December 31, 2019, compared to $8,571 million for the
year ended December 31, 2018. The small increase was due to impairment charges
related to PP&E at various facilities associated with portfolio rationalization
initiatives and indirect tax charges, partially offset by lower raw material
prices in the U.S., Europe, and Brazil.
Gross profit increased by $54 million, or 10%, to $612 million for the year
ended December 31, 2019, compared to $558 million for the year ended
December 31, 2018. The increase was primarily due to higher sales volumes in the
U.S. and Europe, and higher sales volumes and a more favorable product mix in
Argentina. These increases were partially offset by the impairment charges and
indirect tax charges noted above.
SG&A expenses increased $28 million, or 8%, to $376 million for the year ended
December 31, 2019, compared to $348 million for the year ended December 31,
2018. The increase was driven by a full year ownership of Loders, as well as
impairment charges related to the relocation of a distribution center in Brazil,
partially offset by lower costs in Europe and Brazil due to depreciation of the
euro and Brazilian real against the U.S. dollar, and from savings associated
with the GCP.
Other income (expenses) - net increased $98 million, or 426%, to expense of $121
million for the year ended December 31, 2019 compared to expense of $23 million
for the year ended December 31, 2018. The increase in expense was primarily due
to a goodwill impairment charge of $108 million recorded in 2019 associated with
our 2018 acquisition of Loders.
Segment EBIT decreased by $53 million, or 30%, to $121 million for the year
ended December 31, 2019, compared to $174 million for the year ended
December 31, 2018. The decrease was primarily due to the goodwill and other
impairment charges discussed above, partially offset by higher gross profit in
the U.S., Europe, and Argentina also discussed above.
                                       34

--------------------------------------------------------------------------------


  Table of Contents

Milling Products Segment
                                                               Year Ended
                                                              December 31,
(US$ in millions)                                    2020         2019         2018
Volumes (in thousand metric tons)                    4,663        4,531        4,604
Net sales                                          $ 1,648      $ 1,739      $ 1,691
Cost of goods sold                                  (1,477)      (1,579)      (1,461)
Gross profit                                           171          160          230
Selling, general and administrative expense            (97)         (98)    

(105)


Foreign exchange gains (losses)                          6            4     

2


EBIT attributable to noncontrolling interests            -            -     

-


Other income (expense) - net                            (1)          22     

(13)


Income (loss) from affiliates                           (1)           -     

-


Total Milling Products Segment EBIT                $    78      $    88      $   114



2020 Compared to 2019
Milling products segment Net sales decreased by $91 million, or 5%, to $1,648
million for the year ended December 31, 2020, compared to $1,739 million for the
year ended December 31, 2019. The decrease was primarily due to lower average
sales prices in Brazil and Mexico, and lower sales prices in our U.S. corn
milling business, which more than offset higher volumes.
Cost of goods sold decreased by $102 million, or 6%, to $1,477 million for the
year ended December 31, 2020, compared to $1,579 million for the year ended
December 31, 2019. The decrease was due to lower Net sales, as described above,
favorable translation impacts on industrial costs, following the depreciation of
the Brazilian real and Mexican peso versus the U.S. dollar, and approximately
$28 million of non-recurring prior year impairment charges associated with our
U.S. extrusion business and portfolio rationalization initiatives.
Gross profit increased by $11 million, or 7%, to $171 million for the year ended
December 31, 2020, compared to $160 million for the year ended December 31,
2019. The increase was due to a decrease in Cost of goods sold in excess of the
decrease in Net sales, as described above.
SG&A expenses decreased by $1 million, or 1%, to $97 million for the year ended
December 31, 2020, compared to $98 million for the year ended December 31, 2019
as favorable translation impacts and lower travel costs associated with COVID-19
restrictions were offset by higher variable compensation costs on the back of
improved overall company profitability.
Other income (expense) - net decreased by $23 million, or 105%, to expense of
$1 million for the year ended December 31, 2020, compared to income of $22
million for the year ended December 31, 2019. The decrease is primarily due a
$19 million gain on the sale of two facilities in Brazil during the prior year.
Segment EBIT decreased by $10 million, or 11%, to $78 million for the year ended
December 31, 2020, compared to $88 million for the year ended December 31, 2019.
The decrease was primarily due to lower Other income (expense) - net, partially
offset by higher Gross profit, as described above.
2019 Compared to 2018
Milling products segment Net sales increased by $48 million, or 3%, to $1,739
million for the year ended December 31, 2019, compared to $1,691 million for the
year ended December 31, 2018. The increase was primarily driven by higher sales
prices for wheat products in Brazil, the acquisition of two corn mills in the
U.S. ("Minsa") during the first quarter of 2018, and higher sales prices in our
U.S. rice milling business. These increases were partially offset by lower sales
volumes in Mexico.
Cost of goods sold increased by $118 million, or 8%, to $1,579 million for the
year ended December 31, 2019, compared to $1,461 million for the year ended
December 31, 2018. The increase was primarily due to higher raw material costs
in Brazil, higher raw material costs in our U.S. rice milling business,
impairment charges associated with various portfolio rationalization
initiatives, as well as additional costs associated with the acquisition of
Minsa. These increases were partially offset by lower sales volumes in Mexico.
                                       35

--------------------------------------------------------------------------------

Table of Contents



Gross profit decreased by $70 million, or 30%, to $160 million for the year
ended December 31, 2019, compared to $230 million for the year ended
December 31, 2018. The decrease was primarily associated with lower margins in
Brazil, lower volumes in Mexico, and the impairment charges noted above.
SG&A expenses decreased by $7 million, or 7%, to $98 million for the year ended
December 31, 2019, compared to $105 million for the year ended December 31,
2018. The decrease was primarily due to savings from the GCP and the
depreciation of the Brazilian real against the U.S. dollar. Additionally, 2018
was impacted by acquisition costs related to Minsa.
Other income (expenses) - net increased $35 million, to income of $22 million
for the year ended December 31, 2019, compared to expense of $13 million for the
year ended December 31, 2018. The increase was primarily due to a gain on an
arbitration settlement in the U.S. in 2019.
Segment EBIT decreased $26 million, or 23%, to $88 million for the year ended
December 31, 2019, compared to $114 million for the year ended December 31,
2018. The decrease was primarily due to lower gross profit in Brazil and Mexico,
as well as impairment charges associated with certain portfolio rationalization
initiatives, partially offset by a gain on the sale of wheat milling assets in
Brazil, an arbitration settlement gain, and lower overall SG&A expenses.

Fertilizer Segment
                                                              Year Ended
                                                             December 31,
(US$ in millions)                                    2020        2019        2018
Volumes (in thousand metric tons)                   1,537       1,508       1,328
Net sales                                          $  484      $  520      $  460
Cost of goods sold                                   (386)       (442)       (390)
Gross profit                                           98          78          70
Selling, general and administrative expense           (11)        (13)      

(17)


Foreign exchange gains (losses)                         -           -       

(6)

EBIT attributable to noncontrolling interests (2) (3)


   (2)
Other income (expense) - net                            -           -           1
Income (loss) from affiliates                           -           -           -
Total Fertilizer Segment EBIT                      $   85      $   62      $   46


2020 Compared to 2019
Fertilizer segment Net sales decreased by $36 million, or 7%, to $484 million
for the year ended December 31, 2020, compared to $520 million for the year
ended December 31, 2019. The decrease was due to lower average sales prices in
Argentina and Brazil, partially offset by higher sales volumes in Argentina.
Cost of goods sold decreased by $56 million, or 13%, to $386 million for the
year ended December 31, 2020, compared to $442 million for the year ended
December 31, 2019. The decrease was primarily due to lower Net sales, as
described above, as well as favorable translation impacts on industrial costs
following the depreciation of the Brazilian real and Argentinian peso versus the
U.S. dollar.
Gross profit increased $20 million, or 26%, to $98 million for the year ended
December 31, 2020, compared to $78 million for the year ended December 31, 2019.
The increase was primarily due to margin expansion resulting in higher Gross
profit despite lower Net sales.
SG&A expenses decreased $2 million, or 15%, to $11 million for the year ended
December 31, 2020, compared to $13 million for the year ended December 31, 2019.
The decrease was primarily due to a current period bad debt recovery against a
prior year provision, as well as favorable translation impacts.
Segment EBIT increased $23 million, or 37%, to $85 million for the year ended
December 31, 2020, compared to $62 million for the year ended December 31, 2019.
The increase was due to higher Gross profit and lower SG&A expenses, as
described above.
                                       36

--------------------------------------------------------------------------------

Table of Contents



2019 Compared to 2018
Fertilizer segment Net sales increased $60 million, or 13%, to $520 million for
the year ended December 31, 2019, compared to $460 million for the year ended
December 31, 2018. The increase was primarily due to higher sales volumes in
Argentina.
Cost of goods sold increased $52 million, or 13%, to $442 million for the year
ended December 31, 2019, compared to $390 million for the year ended
December 31, 2018. The increase was primarily due to higher sales volumes.
Gross profit increased $8 million, or 11%, to $78 million for the year ended
December 31, 2019, compared to $70 million for the year ended December 31, 2018.
The increase was primarily due to higher sales volumes and favorable foreign
currency impacts compared to the prior year.
SG&A expenses decreased $4 million, or 24%, to $13 million for the year ended
December 31, 2019, compared to $17 million for the year ended December 31, 2018.
The decrease was primarily due to bad debt recoveries during 2019.
Segment EBIT increased $16 million, or 35%, to $62 million for the year ended
December 31, 2019, compared to $46 million for the year ended December 31, 2018.
The increase was primarily due to higher Gross profit, lower overall expenses,
and favorable foreign exchange results.

Corporate and Other
                                                              Year Ended
                                                             December 31,
(US$ in millions)                                    2020        2019        2018
Net sales                                          $    -      $    -      $    -
Cost of goods sold                                     (5)          3         (22)
Gross profit                                           (5)          3         (22)

Selling, general and administrative expense (345) (339)

(348)


Foreign exchange gains (losses)                        (2)          3       

20


EBIT attributable to noncontrolling interests           -           -       

-


Other income (expense) - net                          (13)         88       

8


Income (loss) from affiliates                           -           -       

-


Total Corporate and Other EBIT                     $ (365)     $ (245)     $ (342)



2020 Compared to 2019
Corporate and Other EBIT decreased $120 million, or 49%, to a loss of $365
million for the year ended December 31, 2020, compared to a loss of $245 million
for the year ended December 31, 2019. The decrease is primarily due to higher
current period variable incentive costs on the back of improved overall company
profitability, $66 million in charges for a bad debt reserve in relation to a
disputed account receivable balance stemming from a business transaction dating
back to 2015 and positive prior year mark-to-market results on one of our
corporate venture capital unit investments, partially offset by non-recurring
prior year impairment charges and related employee severance costs associated
with the relocation of our corporate headquarters and lower current period
travel costs due to COVID-19 restrictions.
2019 Compared to 2018
Corporate and Other EBIT increased $97 million, or 28%, to a loss of $245
million for the year ended December 31, 2019, compared to a loss of $342 million
for the year ended December 31, 2018. The increase is primarily due to our
corporate venture capital unit activities, which benefited from the initial
public offering of one of its investments, and subsequent gains on sales of such
securities in 2019, partially offset by costs incurred with the relocation of
our global headquarters.

                                       37

--------------------------------------------------------------------------------


  Table of Contents

Non-core Segment
Sugar & Bioenergy Segment
                                                               Year Ended
                                                              December 31,
(US$ in millions)                                   2020         2019         2018
Volumes (in thousand metric tons)                    334         3,836        6,509
Net sales                                          $ 142      $  1,288      $ 2,257
Cost of goods sold                                  (139)       (2,692)      (2,274)
Gross profit                                           3        (1,404)         (17)
Selling, general and administrative expense            -           (38)     

(74)


Foreign exchange gains (losses)                        -           (89)     

6


EBIT attributable to noncontrolling interests          -             -            1
Other income (expense) - net                           2           (65)         (23)
Income (loss) from affiliates                        (92)           (3)           4
Total Sugar and Bioenergy Segment EBIT             $ (87)     $ (1,599)     $  (103)



2020 Compared to 2019
Sugar and Bioenergy segment Net sales decreased by $1,146 million, or 89%, to
$142 million for the year ended December 31, 2020, compared to $1,288 million
for the year ended December 31, 2019. The decrease in Net sales was primarily
due to the contribution of our Brazilian sugar and bioenergy operations,
comprising the majority of our Sugar and Bioenergy segment, to the BP Bunge
Bioenergia joint venture during the fourth quarter of 2019. Remaining sales
comprise corn-based ethanol distribution activities in North America.
Cost of goods sold decreased by $2,553 million, or 95%, to $139 million for the
year ended December 31, 2020, compared to $2,692 million for the year ended
December 31, 2019. The decrease was primarily due to a significant non-recurring
impairment charge in the third quarter of 2019, in addition to the decrease in
Net sales resulting from the contribution of the majority of our Brazilian sugar
and bioenergy operations to the BP Bunge Bioenergia joint venture during the
fourth quarter of 2019, as described above.
Gross profit increased by $1,407 million, or 100%, to $3 million for the year
ended December 31, 2020, compared to a loss of $1,404 million for the year ended
December 31, 2019. The increase was due to a significant non-recurring
impairment charge in the third quarter of 2019, in addition to the decrease in
Net sales resulting from the contribution of the majority of our Brazilian sugar
and bioenergy operations to the BP Bunge Bioenergia joint venture during the
fourth quarter of 2019, as described above.
SG&A expenses were zero for the year ended December 31, 2020, compared to $38
million for the year ended December 31, 2019. The change was primarily due to
the contribution of the majority of our Brazilian sugar and bioenergy operations
to the BP Bunge Bioenergia joint venture during the fourth quarter of 2019, as
discussed above.
Income (loss) from affiliates decreased by $89 million to a loss of $92 million
for the year ended December 31, 2020, compared to a loss of $3 million for the
year ended December 31, 2019. The decrease was due to our share of losses
associated with our investment in the BP Bunge Bioenergia joint venture.
Segment EBIT increased $1,512 million, or 95%, to a loss of $87 million for the
year ended December 31, 2020, from a loss of $1,599 million for the year ended
December 31, 2019. The increase was mainly due to a significant non-recurring
impairment taken in 2019 and lower SG&A in 2020, partially offset by a decrease
in Income (loss) from affiliates, as described above.
2019 Compared to 2018
Sugar and Bioenergy segment Net sales decreased $969 million, or 43%, to $1,288
million for the year ended December 31, 2019, compared to $2,257 million for the
year ended December 31, 2018. The decrease was primarily due to the exiting of
our international trading and merchandising business in 2018, as well as lower
global sugar sales volumes and prices, partially offset by higher ethanol sales
volumes and prices in Brazil. Additionally, in December 2019 we contributed our
Brazilian sugar and bioenergy operations to our then-newly-formed joint venture,
BP Bunge Bioenergia, as discussed above.
                                       38

--------------------------------------------------------------------------------

Table of Contents



Cost of goods sold increased $418 million, or 18%, to $2,692 million for the
year ended December 31, 2019, compared to $2,274 million for the year ended
December 31, 2018. The increase was primarily due to non-recurring impairment
charges of $1,524 million associated with the contribution of our Brazilian
sugar and bioenergy operations to the BP Bunge Bioenergia joint venture, as
discussed above. This increase was partially offset by lower costs aligned with
the decrease in Net sales noted above.
Gross profit decreased $1,387 million, or 8,159%, to a loss of $1,404 million
for the year ended December 31, 2019, compared to a loss of $17 million for the
year ended December 31, 2018. The decrease was primarily associated with lower
sales and higher costs of goods sold, including the non-recurring impairment
charges associated with the contribution of our Brazilian sugar and bioenergy
operations to the BP Bunge Bioenergia joint venture, as discussed above.
SG&A expenses decreased $36 million, or 49%, to $38 million for the year ended
December 31, 2019, compared to $74 million for the year ended December 31, 2018.
The decrease was primarily associated with the exiting of our international
trading and merchandising business in 2018, lower bad debt expenses, savings and
lower costs associated with the GCP, the impact of depreciation of the Brazilian
real against the U.S. dollar, as well as the contribution of our Brazilian sugar
and bioenergy operations to the BP Bunge Bioenergia joint venture, as discussed
above.
Foreign exchange gains (losses), on a net basis, decreased $95 million, or
1,583%, to a loss of $89 million for the year ended December 31, 2019, compared
to a gain of $6 million for the year ended December 31, 2018. Foreign exchange
losses in 2019 were primarily associated with intercompany loans related to our
Brazilian sugar and bioenergy operations that were classified as held for sale
in the third quarter of 2019. Previously, these loans were classified as
permanently invested and any related foreign exchange impact was recorded in
Other comprehensive income (loss). However, upon classification of our sugar and
bioenergy operations as held for sale, such loans could no longer be determined
to be permanently invested. As such, any foreign exchange impact was recorded in
the consolidated statement of income.
Other income (expense) - net was a loss of $65 million for the year ended
December 31, 2019, compared to a loss of $23 million for the year ended
December 31, 2018. The increase in expense was primarily related to charges
associated with the contribution of our Brazilian sugar and bioenergy operations
to our newly formed joint-venture, BP Bunge Bioenergia, as discussed above.
Segment EBIT decreased by $1,496 million, or 1,452% to a loss of $1,599 million
for the year ended December 31, 2019, compared to a loss of $103 million for the
year ended December 31, 2018. The decrease was mainly due to $1,673 million in
non-recurring charges incurred in 2019 associated with the contribution of our
Brazilian sugar and bioenergy operations to the BP Bunge Bioenergia joint
venture, as discussed above.

Interest-A summary of consolidated interest income and expense follows:


                                Year Ended
                               December 31,
(US$ in millions)       2020       2019       2018
Interest income        $  22      $  31      $  31
Interest expense        (265)      (339)      (339)


Interest income decreased $9 million to $22 million for the year ended
December 31, 2020, compared to $31 million for the year ended December 31, 2019.
Interest expense decreased $74 million to $265 million for the year ended
December 31, 2020, compared to $339 million for the year ended December 31,
2019. The net decrease was the result of lower average interest rates on
outstanding debt during the current year.
Interest income remained constant during 2019 and 2018 at $31 million. Interest
expense also remained constant at $339 million in 2019 and 2018. Average debt
balances were lower in 2019 than in 2018, however total interest expense
remained flat due to interest rates applicable to our overall debt mix.

Liquidity and Capital Resources
Our main financial objectives are to prudently manage financial risks, ensure
consistent access to liquidity and minimize cost of capital in order to
efficiently finance our business and maintain balance sheet strength. We
generally finance our ongoing operations with cash flows generated from
operations, issuance of commercial paper, borrowings under various bilateral and
syndicated revolving credit facilities, term loans and proceeds from the
issuance of senior notes. Acquisitions and long-lived assets are generally
financed with a combination of equity and long-term debt.
                                       39

--------------------------------------------------------------------------------

Table of Contents

Working Capital


                                              As of December 31,
US$ in millions, except current ratio         2020           2019
Cash and cash equivalents                 $      352      $    320
Trade accounts receivable, net                 1,717         1,705
Inventories                                    7,172         5,038
Other current assets(1)                        6,940         3,185
Total current assets                      $   16,181      $ 10,248
Short-term debt                           $    2,828      $    771
Current portion of long-term debt                  8           507
Trade accounts payable                         2,636         2,842
Current operating lease obligations              235           216
Other current liabilities(2)                   5,278         2,259
Total current liabilities                 $   10,985      $  6,595
Working capital(3)                        $    5,196      $  3,653
Current ratio(3)                                1.47          1.55

(1)Comprises Assets held for sale and Other current assets (2)Comprises Liabilities held for sale and Other current liabilities

(3)Working capital is defined as Total current assets less Total current liabilities; Current ratio represents Total current assets divided by Total current liabilities



Working capital was $5,196 million at December 31, 2020, an increase of $1,543
million, or 42%, from working capital of $3,653 million at December 31, 2019.
Cash and Cash Equivalents - Cash and cash equivalents were $352 million at
December 31, 2020, an increase of $32 million from $320 million at December 31,
2019. Cash balances are managed in accordance with our investment policy, the
objectives of which are to preserve the principal value of our cash assets,
maintain a high degree of liquidity and deliver competitive returns subject to
prevailing market conditions. Cash balances are invested in short-term deposits
with highly rated financial institutions and in U.S. government securities.
Trade accounts receivable, net - Trade accounts receivable, net were $1,717
million at December 31, 2020, an increase of $12 million from $1,705 million at
December 31, 2019. The increase is primarily due to the timing of collections in
our trading and distribution business, mostly offset by negative foreign
exchange impacts in Brazil, and the recording of a bad debt reserve in relation
to collection proceedings involving an historical outstanding account receivable
due from a customer.

Inventories - Inventories were $7,172 million at December 31, 2020, an increase
of $2,134 million from $5,038 million at December 31, 2019. The increase is
primarily related to an increase in RMI resulting from higher commodity prices
in the current year, coupled with increased inventory quantities on hand
following our deliberate decision to increase volumes during the year to
optimize our earnings potential.
RMI comprises agricultural commodity inventories, including soybeans, soybean
meal, soybean oil, corn, and wheat that are readily convertible to cash because
of their commodity characteristics, widely available markets and international
pricing mechanisms. Total RMI reported at fair value were $5,961 million and
$3,934 million at December 31, 2020 and December 31, 2019, respectively (see
Note 5- Inventories, to our consolidated financial statements included as part
of this Annual Report on Form 10-K).
Other current assets - Other current assets were $6,940 million at December 31,
2020, an increase of $3,755 million from $3,185 million at December 31, 2019.
The increase is primarily due to unrealized gains on derivative contracts, as
well as the reclassification of certain of our U.S. grain assets and our oils
refinery in Rotterdam, Netherlands as held for sale (see Note 2- Portfolio
Rationalization Initiatives, to our consolidated financial statements).

                                       40

--------------------------------------------------------------------------------

Table of Contents



Short-term debt - Short-term debt, including the current portion of long-term
debt, was $2,836 million at December 31, 2020, an increase of $1,558 million
from $1,278 million at December 31, 2019. The increase was to fund higher
seasonal working capital levels, primarily RMI.

Trade accounts payable - Trade accounts payable were $2,636 million at
December 31, 2020, a decrease of $206 million from $2,842 million at
December 31, 2019. The decrease is due to the timing of payments on account as
well as the reclassification of liabilities associated with certain of our U.S.
grain assets and our oils refinery in Rotterdam, Netherlands as held for sale.

Other current liabilities - Other current liabilities were $5,278 million at December 31, 2020, an increase of $3,019 million from $2,259 million at December 31, 2019. The increase is primarily due to unrealized losses on derivative contracts and Liabilities held for sale (see Note 2- Portfolio Rationalization Initiatives, to our consolidated financial statements).

Debt


Financing Arrangements and Outstanding Indebtedness-We conduct most of our
financing activities through a centralized financing structure that provides the
company efficient access to debt and capital markets. This structure includes a
master trust, of which the primary assets consist of intercompany loans made to
Bunge Limited and its subsidiaries. Certain of Bunge Limited's 100% owned
finance subsidiaries, Bunge Limited Finance Corp., Bunge Finance Europe B.V. and
Bunge Asset Funding Corp., fund the master trust with short and long-term debt
obtained from third parties, including through our commercial paper program and
certain credit facilities, as well as the issuance of senior notes. Borrowings
by these finance subsidiaries carry full, unconditional guarantees by Bunge
Limited.
Revolving Credit Facilities-At December 31, 2020, we had $5,565 million of
aggregate committed borrowing capacity under our commercial paper program and
various revolving bilateral and syndicated credit facilities, of which $4,072
million was unused and available. The following table summarizes these
facilities as of the periods presented:
                                                                                    Total Committed                          Borrowings
                                                                                        Capacity                             Outstanding
Commercial Paper Program and Revolving Credit                                                                 December 31,
Facilities                                                 Maturities              December 31, 2020              2020               December 31, 2019

Commercial Paper                                              2023                $             600          $        549          $                -
Revolving Credit Facilities                                2021 - 2023                        4,965                   944                           -
Total                                                                             $           5,565          $      1,493          $                -




On October 22, 2020, we entered into an unsecured $1,250 million 364-day
Revolving Credit Agreement (the "Credit Agreement") with a group of lenders. The
Credit Agreement includes a $1,000 million tranche ("Tranche A") and a
$250 million tranche ("Tranche B"). Borrowings under the Credit Agreement will
bear interest at LIBOR plus an applicable margin, as defined in the Credit
Agreement. Each lender under Tranche A is required to fund all borrowing
requests delivered by us unless such lender has delivered a declining lender
notice to the administrative agent by 9.00am (New York City time) on the date
such borrowing request is delivered. The lenders under Tranche B do not have the
right to deliver a declining lender notice to us. We may also, from time to
time, request one or more of the existing or new lenders to increase the total
participations and commitments under Tranche A and Tranche B of the Credit
Agreement by an aggregate amount up to $250 million pursuant to an accordion
provision. The Credit Agreement matures on October 21, 2021. We had $250 million
outstanding at December 31, 2020, under the Revolving Credit Facility.
We had $554 million of borrowings outstanding at December 31, 2020 under our
$1,750 million unsecured syndicated revolving credit facility with certain
lenders party thereto maturing December 12, 2022 (the ''$1.75 Billion 2022
Facility''). Borrowings under the $1.75 Billion 2022 Facility bear interest at
LIBOR plus a margin, which will vary from 0.30% to 1.30% per annum, based on the
credit ratings of our senior long-term unsecured debt. The applicable margin is
also subject to certain premiums or discounts tied to criteria determined by
certain sustainability targets. We also pay a fee that varies from 0.10% to
0.40% per annum, based on the utilization of the $1.75 Billion 2022 Facility.
Amounts under the $1.75 Billion 2022 Facility that remain undrawn are subject to
a commitment fee payable quarterly in arrears at a rate of 35% of the margin
specified above, which varies based on the rating level at each quarterly
payment date. We may, from time to time, with the consent of the facility agent,
request one or more of the existing lenders or new lenders to increase the total
commitments under the $1.75 Billion 2022 Facility by up to $250 million pursuant
to an accordion provision.
                                       41

--------------------------------------------------------------------------------

Table of Contents



We had no borrowings outstanding at December 31, 2020 under our unsecured $1,100
million five-year syndicated revolving credit agreement (the "Credit Agreement")
with certain lenders party thereto maturing December 14, 2023. We have the
option to request an extension of the maturity date of the Credit Agreement for
two additional one-year periods, subject to the consent of the lenders.
Borrowings under the Credit Agreement will bear interest at LIBOR plus a margin,
which will vary from 1.00% to 1.625%, based on the credit ratings of our senior
long-term unsecured debt ("Rating Level"). Amounts under the Credit Agreement
that remain undrawn are subject to a commitment fee at rates ranging from 0.09%
to 0.225%, varying based on the Rating Level. We may, from time to time, request
one or more of the existing lenders or new lenders to increase the total
commitments under the Credit Agreement by up to $200 million pursuant to an
accordion provision.
We had $140 million of borrowings outstanding at December 31, 2020 under our
unsecured $865 million revolving credit facility, maturing September 6, 2022
(the "2022 Facility"). Borrowings under the 2022 Facility bear interest at LIBOR
plus a margin, which will vary from 1.00% to 1.75% per annum, based on the
credit ratings of our senior long-term unsecured debt. Amounts under the 2022
Facility that remain undrawn are subject to a commitment fee payable quarterly
based on the average undrawn portion of the 2022 Facility at rates ranging from
0.125% to 0.275%, based on the credit ratings of our senior long-term unsecured
debt.
Our commercial paper program is supported by committed back-up bank credit lines
(the ''Liquidity Facility'') equal to the amount of the commercial paper program
provided by lending institutions that are required to be rated at least A-1 by
Standard & Poor's and P-1 by Moody's Investor Services. The cost of borrowing
under the Liquidity Facility would typically be higher than the cost of issuance
under our commercial paper program. At December 31, 2020, $549 million of
borrowings were outstanding under the commercial paper program and no borrowings
were outstanding under the Liquidity Facility. The Liquidity Facility is our
only revolving credit facility that requires lenders to maintain minimum credit
ratings.
In addition to committed credit facilities, from time to time, through our
financing subsidiaries, we enter into bilateral short-term credit lines as
necessary based on our financing requirements. At December 31, 2020 there were
$550 million of borrowings outstanding under these bilateral short-term credit
lines.
Short and long-term debt-Our short and long-term debt increased by $2,294
million at December 31, 2020 from December 31, 2019, primarily due to increased
working capital requirements at the end of the year. For the year ended
December 31, 2020, our average short and long-term debt outstanding was
approximately $6,100 million compared to approximately $6,142 million for the
year ended December 31, 2019. Our long-term debt outstanding balance, including
the current-portion of such long-term debt, was $4,460 million at December 31,
2020 compared to $4,223 million at December 31, 2019. The following table
summarizes our short-term debt activity at December 31, 2020.
                                               Weighted                                       Weighted
                                               Average           Highest                      Average
                           Outstanding         Interest          Balance         Average      Interest
                           Balance at          Rate at         Outstanding       Balance        Rate
                          December 31,       December 31,         During         During        During
(US$ in millions)             2020               2020              2020           2020          2020
Bank Borrowings (1)      $       2,279             6.75  %    $      2,565      $ 1,272         7.30  %
Commercial Paper                   549             0.27  %             599          341         0.80  %
Total                    $       2,828             5.49  %                      $ 1,613         5.92  %




(1)Includes $558 million of local currency borrowings in certain Central and
Eastern European, South American, and Asia-Pacific countries at a local currency
based weighted average interest rate of 24.54% as of December 31, 2020.

On August 17, 2020, we completed the sale and issuance of $600 million aggregate
principal amount of 1.630% unsecured senior notes ("Notes") due August 17, 2025.
The Notes are fully and unconditionally guaranteed by Bunge. The offering was
made pursuant to a shelf registration statement on Form S-3 (Registration No.
333-231083) filed by Bunge Limited and BLFC with the U.S. Securities and
Exchange Commission. Interest on the Notes is payable semi-annually in arrears
in February and August of each year, commencing on February 17, 2021. At any
time prior to July 17, 2025 (one month before maturity of the Notes), we may
elect to redeem and repay the Notes, at any time in whole, or from time to time
in part, at a redemption price equal to 100% of the principal amount of the
Notes being redeemed on the redemption date. The net proceeds of the offering
were approximately $595 million after deducting underwriting commissions, the
original issue discount and offering fees and expense payable by us. We used the
net proceeds from this offering for general corporate purposes, including the
repayment of certain short-term debt that included borrowings under the
commercial paper program.
                                       42

--------------------------------------------------------------------------------

Table of Contents

The following table summarizes our short and long-term debt:


                                                                            December 31,
(US$ in millions)                                                        2020         2019
Short-term debt: (1)
Short-term debt (2)                                                    $ 2,828      $   771
Current portion of long-term debt                                            8          507
Total short-term debt                                                    2,836        1,278
Long-term debt:
Term loan due 2024 - three-month Yen LIBOR plus 0.75% (Tranche A)          297          281
Term loan due 2024 - three-month LIBOR plus 1.30% (Tranche B)               89           89

3.50% Senior Notes due 2020                                                  -          499
3.00% Senior Notes due 2022                                                399          398
1.85% Senior Notes due 2023 - Euro                                         982          899
4.35% Senior Notes due 2024                                                597          596
1.63% Senior Notes due 2025                                                595            -
3.25% Senior Notes due 2026                                                696          696
3.75% Senior Notes due 2027                                                595          595
Other                                                                      210          170
  Subtotal                                                               4,460        4,223
Less: Current portion of long-term debt                                     (8)        (507)
Total long-term debt (3)                                                 4,452        3,716
Total debt                                                             $ 7,288      $ 4,994




(1)  Includes secured debt of $1 million and $1 million at December 31, 2020 and
December 31, 2019, respectively.
(2)  Includes $558 million and $348 million of local currency borrowings in
certain Central and Eastern European, South American, and Asia-Pacific countries
at a weighted average interest rate of 24.54% and 27.16% as of December 31, 2020
and December 31, 2019, respectively.
(3)  Includes secured debt of $5 million and $15 million at December 31, 2020
and December 31, 2019, respectively.
We have also entered into standby letters of credit and surety bonds with
financial institutions primarily relating to the guarantee of our future
performance on certain contracts. Contingent liabilities on outstanding standby
letter of credit agreements and surety bonds aggregated to $1,226 million and
$1,156 million as of December 31, 2020 and 2019, respectively.
Credit Ratings-Bunge's debt ratings and outlook by major credit rating agencies
at December 31, 2020 were as follows:
                      Short-term        Long-term
                       Debt(1)            Debt           Outlook
Standard & Poor's        A-1               BBB           Stable
Moody's                  P-1              Baa3           Stable
Fitch                     F1              BBB-           Stable




(1)Short-term rating applies only to Bunge Asset Funding Corp., the issuer under
our commercial paper program.
Our debt agreements do not have any credit rating downgrade triggers that would
accelerate the maturity of our debt. However, credit rating downgrades would
increase our borrowing costs under our credit facilities and, depending on their
severity, could impede our ability to obtain credit facilities or access the
capital markets in the future on competitive terms. A significant increase in
our borrowing costs could impair our ability to compete effectively in our
business relative to competitors with higher credit ratings.
                                       43

--------------------------------------------------------------------------------

Table of Contents



Our credit facilities and certain senior notes require us to comply with
specified financial covenants, including minimum net worth, minimum current
ratio, a maximum debt to capitalization ratio, and limitations on secured
indebtedness. We were in compliance with these covenants as of December 31,
2020.
Trade Receivable Securitization Program-The Company, and certain of its
subsidiaries participate in a trade receivable securitization program (the
"Program") with a financial institution, as administrative agent, and certain
commercial paper conduit purchasers and committed purchasers (collectively, the
"Purchasers") that provides for funding of up to $800 million against
receivables sold into the Program. The Program, which provides us with an
additional source of liquidity, terminates on May 26, 2021.
Our risk of loss following the sale of the trade receivables under the program
is limited to the deferred purchase price receivable (the "DPP"), which at
December 31, 2020 and 2019 had a fair value of $177 million and $105 million,
respectively, and is included in other current assets in our consolidated
balance sheets (see Note 4- Trade Accounts Receivable and Trade Receivable
Securitization Program, to our consolidated financial statements included as
part of this Annual Report on Form 10-K). The DPP will be repaid in cash as
receivables are collected, generally within 30 days. Delinquencies and credit
losses on trade receivables sold under the Program during the years ended
December 31, 2020, 2019 and 2018 were insignificant.
Interest Rate Swap Agreements-We may use interest rate swaps as hedging
instruments and record the swaps at fair value in the consolidated balance
sheets with changes in fair value recorded contemporaneously in earnings.
Additionally, the carrying amount of the associated debt is adjusted through
earnings for changes in the fair value due to changes in benchmark interest
rates.
Equity-Total equity is set forth in the following table:
                                                                         December 31,
(US$ in millions)                                                     2020  

2019


Convertible perpetual preference shares                             $   690      $   690
Common shares                                                             1            1
Additional paid-in capital                                            5,408        5,329
Retained earnings                                                     7,236        6,437
Accumulated other comprehensive income                               (6,246)      (5,624)
Treasury shares, at cost (2020-15,428,313 and 2019-12,882,313)       (1,020)        (920)
Total Bunge shareholders' equity                                      6,069        5,913
Noncontrolling interests                                                136          117
Total equity                                                        $ 6,205      $ 6,030


Total Bunge shareholders' equity was $6,069 million at December 31, 2020
compared to $5,913 million at December 31, 2019. The increase in Bunge
shareholders' equity during the year ended December 31, 2020 was primarily due
to $1,145 million of Net income attributable to Bunge, offset by $622 million of
Other comprehensive loss, primarily currency translation adjustment, $282
million and $34 million of declared dividends to common and preferred
shareholders, respectively, and $100 million of common share repurchases.
Noncontrolling interest increased to $136 million at December 31, 2020 from $117
million at December 31, 2019 primarily due to Net income attributable to our
noncontrolling interest entities, offset by dividends paid to non-controlling
interest holders.
At December 31, 2020, we had 6,899,683 4.875% cumulative convertible perpetual
preference shares outstanding with an aggregate liquidation preference of $690
million. Each convertible perpetual preference share has an initial liquidation
preference of $100, which will be adjusted for any accumulated and unpaid
dividends. The convertible perpetual preference shares carry an annual dividend
of $4.875 per share payable quarterly. As a result of adjustments made to the
initial conversion price because cash dividends paid on Bunge Limited's common
shares exceeded certain specified thresholds, each convertible perpetual
preference share is convertible, at the holder's option, at any time into 1.2585
Bunge Limited common shares, based on the conversion price of $79.4592 per
share, subject to certain additional anti-dilution adjustments (which represents
8,683,251 Bunge Limited common shares at December 31, 2020). At any time, if the
closing price of our common shares equals or exceeds 130% of the conversion
price for 20 trading days during any consecutive 30 trading days (including the
last trading day of such period), we may elect to cause the convertible
perpetual preference shares to be automatically converted into Bunge Limited
common shares at the then-prevailing conversion price. The convertible perpetual
preference shares are not redeemable by us at any time.
                                       44

--------------------------------------------------------------------------------

Table of Contents



Share repurchase program - In May 2015, we established a program for the
repurchase of up to $500 million of our issued and outstanding common shares.
The program has no expiration date. Bunge repurchased 2,546,000 common shares
under this program during the year ended December 31, 2020, for $100 million.
Total repurchases under the program from its inception in May 2015 through
December 31, 2020 were 7,253,440 shares for $400 million.

Cash Flows
                                                                      Year ended December 31,
US$ in millions                                           2020                  2019                 2018
Cash provided by (used for) operating
activities                                           $     (3,536)         $      (808)         $    (1,264)
Cash provided by (used for) investing
activities                                                  1,813                1,503                  410
Cash provided by (used for) financing
activities                                                  1,763                 (771)                 631
Effect of exchange rate changes on cash and
cash equivalents and restricted cash                           19                    5                   11
Net increase (decrease) in cash and cash
equivalents and restricted cash                      $         59          

$ (71) $ (212)




Our cash flows from operations vary depending on, among other items, the market
prices and timing of the purchase and sale of our inventories. Generally, during
periods when commodity prices are rising, our Agribusiness operations require
increased use of cash to support working capital to acquire inventories and fund
daily settlement requirements on exchange traded futures that we use to minimize
price risk related to the purchase and sale of our inventories.
2020 Compared to 2019
For the year ended December 31, 2020, our cash and cash equivalents, and
restricted cash increased $59 million, compared to a decrease of $71 million for
the year ended December 31, 2019.
Operating: Cash used for operating activities was $3,536 million for the year
ended December 31, 2020, an increase of $2,728 million compared to cash used for
operating activities of $808 million for the year ended December 31, 2019. The
increase was due to higher working capital funding requirements, primarily RMI
and proceeds from beneficial interests in securitized trade receivables, both
primarily driven by higher commodity prices, partially offset by higher net
income during the year ended December 31, 2020.
                                                                        Year ended December 31,
US$ in millions                                                        2020                   2019
Cash provided by (used for) operating activities                 $       

(3,536) $ (808) Proceeds from beneficial interest in securitized trade receivables

                                                               1,943                1,312

Cash provided by (used for) operating activities, adjusted $ (1,593) $ 504




Cash used for operating activities, adjusted for proceeds from beneficial
interest in securitized trade receivables was $1,593 million for the year ended
December 31, 2020, compared to cash provided by operating activities of
$504 million for the year ended December 31, 2019. The change in cash provided
by (used for) operating activities is due to higher working capital funding
requirements, primarily RMI, partially offset by higher net income during the
year ended December 31, 2020.
Certain of our non-U.S. operating subsidiaries are primarily funded with U.S.
dollar-denominated debt, while currency risk is hedged with U.S.
dollar-denominated assets. The functional currency of our operating subsidiaries
is generally the local currency. The financial statements of our subsidiaries
are calculated in the functional currency, and when the local currency is the
functional currency, translated into U.S. dollar. U.S. dollar-denominated loans
are remeasured into their respective functional currencies at exchange rates at
the applicable balance sheet date. Also, certain of our U.S. dollar functional
operating subsidiaries outside the U.S. are partially funded with local currency
borrowings, while the currency risk is hedged with local currency denominated
assets. Local currency loans in U.S. dollar functional currency subsidiaries
outside the U.S. are remeasured into U.S. dollars at the exchange rate on the
applicable balance sheet date. The resulting gain or loss is included in our
consolidated statements of income as foreign exchange gains or losses. For the
year ended December 31, 2020 we recorded a foreign currency gain on net debt of
$206 million versus a foreign currency loss on net debt for the year ended
December 31, 2019 of $139 million, which were included as adjustments to
reconcile Net income to Cash used for operating activities in the line item
"Foreign exchange (gain) loss on net debt" in our consolidated statements of
cash flows. This adjustment is required
                                       45

--------------------------------------------------------------------------------

Table of Contents



as these losses are non-cash items that arise from financing activities and
therefore will have no impact on cash flows from operations.
Investing: Cash provided by investing activities was $1,813 million for the year
ended December 31, 2020 compared to $1,503 million for the year ended
December 31, 2019, an increase of $310 million. The increase was primarily due
to higher proceeds from beneficial interests in securitized trade receivables,
lower capital expenditures, and higher cash inflows from settlements of net
investment hedges, offset by lower net proceeds from investments and the
divestiture of businesses and property, plant and equipment for the year ended
December 31, 2020.
For the year ended December 31, 2020, cash from beneficial interests in
securitized trade receivables was $1,943 million. In addition, we received
proceeds from investments of $305 million, primarily promissory notes related to
financial services investments, which were more than offset by payments of $337
million for such investments. We also made payments for capital expenditures of
$365 million related to capital projects at various facilities. For the year
ended December 31, 2019, cash from beneficial interests in securitized trade
receivables was $1,312 million. In addition, we received proceeds from
investments of $449 million, primarily from promissory notes related to
financial services investments, partially offset by payments of $393 million
made for such investments. We also made payments for capital expenditures of
$524 million, which primarily related to the replanting of sugarcane in our
Brazilian sugar and biofuels business that was contributed to the BP Bunge
Bioenergia joint venture in late 2019, as well as other capital projects at
various facilities.
Financing: Cash provided by financing activities was $1,763 million for the year
ended December 31, 2020, an increase of $2,534 million, compared to cash used by
financing activities of $771 million for the year ended December 31, 2019,
For the year ended December 31, 2020, we had net cash proceeds from short-term
and long-term debt of $2,202 million, primarily used to fund seasonal working
capital requirements, mostly comprising RMI. We also paid dividends of $316
million to our common shareholders and holders of our convertible preference
shares, and repurchased $100 million of common shares. For the year ended
December 31, 2019, net cash repayments from short-term and long-term debt were
$438 million, primarily due to lower overall debt needs following the transfer
of our industrial sugar business in Brazil to the BP Bunge Bioenergia joint
venture. In addition, we paid dividends of $317 million to our common
shareholders and holders of our convertible preference shares.
2019 Compared to 2018
In 2019, our cash and cash equivalents, and restricted cash decreased by $71
million, compared to a decrease of $212 million in 2018.
Operating: Cash used for operating activities was $808 million for the year
ended December 31, 2019, compared to cash used for operating activities of
$1,264 million for the year ended December 31, 2018. Net cash outflows from
operating activities was lower for the year ended December 31, 2019, primarily
due to the lower use of cash associated with beneficial interests in securitized
trade receivables, partially offset by higher working capital requirements, when
compared to the year ended December 31, 2018.
                                                                       Year ended December 31,
US$ in millions                                                       2019                  2018
Cash provided by (used for) operating activities                 $       

(808) $ (1,264) Proceeds from beneficial interest in securitized trade receivables

                                                             1,312                1,888

Cash provided by (used for) operating activities, adjusted $ 504 $ 624




Cash provided by operating activities, adjusted for proceeds from beneficial
interest in securitized trade receivables was $504 million for the year ended
December 31, 2019, compared to $624 million for the year ended December 31,
2018. The decrease was due to lower net income and higher working capital
requirements when compared to the year ended December 31, 2018.
For the years ended December 31, 2019 and December 31, 2018, we recorded foreign
currency losses of $139 million and $139 million, respectively, which were
included as adjustments to reconcile Net income to Cash used for operating
activities in the line item "Foreign exchange (gain) loss on net debt" in our
consolidated statements of cash flows. This adjustment is required as these
gains or losses are non-cash items that arise from financing activities and
therefore will have no impact on cash flows from operations.
Investing: Cash provided by investing activities was $1,503 million for the year
ended December 31, 2019 compared to cash provided by investing activities of
$410 million for the year ended December 31, 2018. During 2019, payments were
made for capital expenditures of $524 million, primarily related to replanting
of sugarcane for our industrial sugar business in Brazil,
                                       46

--------------------------------------------------------------------------------

Table of Contents



which were subsequently transferred to the BP Bunge Bioenergia joint venture in
December 2019, as well as other capital projects at various facilities. In
addition, payments were made for investments of $393 million, primarily related
to deposits in South America and promissory notes related to financial services,
which were more than offset by proceeds from such investments and the sale of
equity securities associated with an investment subsequent to its initial public
offering of $449 million. Cash provided by investing activities was primarily
associated with proceeds of $1,312 million from beneficial interests in
securitized trade receivables and $729 million from the divestiture of
businesses and disposals of property, plant, and equipment. During 2018,
payments were made for capital expenditures of $493 million, primarily related
to replanting of sugarcane for our industrial sugar business in Brazil, which
were subsequently transferred to the BP Bunge Bioenergia joint venture in
December 2019, and the upgrade of our crush facility in Italy, as well as other
capital projects at various facilities. In addition, we acquired Loders for $908
million, net of cash acquired, and Minsa USA for $73 million, net of cash
acquired. Further, payments were made for investments of $1,184 million,
primarily related to deposits, treasuries and bonds in South America related to
financial services, which were substantially offset by proceeds from such
investments of $1,098 million. Cash provided by investing activities was
primarily associated with proceeds of $1,888 million from beneficial interests
in securitized trade receivables, as well as cash inflows related to settlements
of net investment hedges of $66 million in the year ended December 31, 2018,
primarily driven by the depreciation of the Brazilian real relative to the U.S.
dollar in 2018.
Financing: Cash used for financing activities was $771 million in the year ended
December 31, 2019, compared to cash provided by financing activities of $631
million for the year ended December 31, 2018. For the year ended December 31,
2019, net cash repayments from short-term and long-term debt were $438 million,
primarily related to lower overall debt needs following the transfer of our
industrial sugar business in Brazil to the BP Bioenergia joint venture. In
addition, we paid dividends of $317 million to our common shareholders and
holders of our convertible preference shares. For the year ended December 31,
2018, net cash proceeds from short-term and long-term debt were $956 million,
primarily related to the funding of acquisitions, capital expenditures and
working capital needs. In 2018, dividends paid to our common shareholders and
holders of our convertible preference shares were $305 million.
Brazilian Farmer Credit
Background-We advance collateralized funds to counterparties (farmers and crop
resellers), primarily to secure the origination of soybeans for our soybean
processing facilities in Brazil. These activities are generally intended to be
short-term in nature. The ability of our counterparties to repay these amounts
is affected by agricultural economic conditions in the relevant geography, which
are, in turn, affected by commodity prices, currency exchange rates, crop input
costs and crop quality and yields. As a result, these arrangements are typically
secured, including by a farmer's crop and, in many cases, land and other assets.
In the event of counterparty default, we generally initiate legal proceedings to
recover the defaulted amounts. However, the legal recovery process through the
judicial system is a long-term process, generally spanning a number of years.
Additionally, we may seek to renegotiate certain terms of our contract with the
defaulting supplier in order to accelerate the recovery of amounts owed.
Because Brazilian farmer credit exposures are denominated in local currency,
reported values are impacted by movements in the value of the Brazilian real
when translated into U.S. dollars. From December 31, 2019 to December 31, 2020,
the Brazilian real depreciated by approximately 23%, decreasing the reported
farmer credit exposure balances when translated into U.S. dollars.
We periodically evaluate the collectability of our farmer receivables and record
allowances if we determine that collection is doubtful. We base our
determination of the allowance on analyses of the credit quality of individual
accounts, also considering the economic and financial condition of the farming
industry and other market conditions, as well as the value of any collateral
related to amounts owed. We continuously review defaulted farmer receivables for
impairment on an individual account basis. We consider all accounts in legal
collections processes to be defaulted and past due. For such accounts, we
determine the allowance for uncollectible amounts based on the fair value of the
associated collateral, net of estimated costs to sell. For all renegotiated
accounts (current and past due), we consider changes in farm economic conditions
and other market conditions, our historical experience related to renegotiated
accounts, and the fair value of collateral in determining the allowance for
doubtful accounts.
Secured Advances to Suppliers and Prepaid Commodity Contracts-We purchase
soybeans through prepaid commodity purchase contracts (advance cash payments to
suppliers against contractual obligations to deliver specified quantities of
soybeans in the future) and secured advances to suppliers (advances to suppliers
against commitments to deliver soybeans in the future), primarily in Brazil.
These financing arrangements are typically secured by the farmer's future crop
and mortgages on the farmer's land, buildings and equipment, and are generally
settled after the farmer's crop is harvested and sold.
Interest earned on secured advances to suppliers of $31 million, $26 million and
$30 million for the years ended December 31, 2020, 2019 and 2018, respectively,
is included in Net sales in the consolidated statements of income.
                                       47

--------------------------------------------------------------------------------

Table of Contents



The table below shows details of prepaid commodity contracts and secured
advances to suppliers outstanding at our Brazilian operations as of the dates
indicated. See Note 6- Other Current Assets and Note 12- Other Non-Current
Assets, to our consolidated financial statements included as part of this Annual
Report on Form 10-K for more information.
                                                                       December 31,
(US$ in millions)                                                    2020   

2019


Prepaid commodity contracts                                        $   141      $  98
Secured advances to suppliers (current)                                374  

336


Total (current)                                                        515  

434


Commodities not yet priced(1)                                          (30) 

(9)


Net                                                                    485  

425


Secured advances to suppliers (non-current)                             81  

134


Total (current and non-current)                                        566  

559

Allowance for uncollectible amounts (current and non-current) $ (43)

$ (65)





(1)Commodities delivered by suppliers that are yet to be priced are reflected at
prevailing market prices at December 31, 2020 and 2019.
Capital Expenditures
Our cash payments made for capital expenditures were $365 million, $524 million
and $493 million for the years ended December 31, 2020, 2019 and 2018,
respectively. We intend to make capital expenditures of approximately $450
million in 2021. Our priorities for 2021 are to maintain the cash generating
capacity of our assets through non-discretionary projects, such as maintenance,
safety and compliance, as well as discretionary investment in growth and
productivity projects, focusing on our strategy to strengthen our oilseeds
platform, increase participation in biofuels and plant-based proteins, as well
as growing our value added oils business. We intend to fund these capital
expenditures primarily with cash flows from operations.
Off-Balance Sheet Arrangements
Guarantees
We have issued or were party to the following guarantees at December 31, 2020:
                                              Maximum Potential
(US$ in millions)                              Future Payments
Unconsolidated affiliates guarantee (1)      $              267
Residual value guarantee (2)                                258
Total                                        $              525





(1)We have issued guarantees to certain financial institutions related to debt
of certain of our unconsolidated affiliates. The terms of the guarantees are
equal to the terms of the related financings which have maturity dates through
2034. There are no recourse provisions or collateral that would enable us to
recover any amounts paid under these guarantees. In addition, one of our
subsidiaries has guaranteed the obligations of two of its affiliates and in
connection therewith has secured its guarantee obligations through a pledge of
one of its affiliate's shares plus loans receivable from the affiliate to the
financial institutions in the event that the guaranteed obligations are
enforced. Based on the amounts drawn under such debt facilities at December 31,
2020, our potential liability was $245 million and we have recorded a $12
million obligation related to these guarantees.
(2)We have issued guarantees to certain financial institutions which are party
to certain operating lease arrangements for railcars and barges. These
guarantees provide for a minimum residual value to be received by the lessor at
conclusion of the lease term. These leases expire at various dates from 2021
through 2026. At December 31, 2020, no obligation has been recorded related to
these guarantees. Any obligation recorded would be recognized in Current
operating lease obligations or Non-current operating lease obligations (see Note
27- Leases, to our consolidated financial statements).
                                       48

--------------------------------------------------------------------------------

Table of Contents



We have provided a guaranty to the Director of the Illinois Department of
Agriculture as Trustee for Bunge North America, Inc. ("BNA"), an indirect
wholly-owned subsidiary, which guarantees all amounts due and owing by BNA, to
grain producers and/or depositors in the State of Illinois who have delivered
commodities to BNA's Illinois facilities.
In addition, we have provided full and unconditional parent level guarantees of
the outstanding indebtedness under certain credit facilities entered into, and
senior notes issued by, our subsidiaries. At December 31, 2020, our consolidated
balance sheet includes debt with a carrying amount of $6,760 million related to
these guarantees. This debt includes the senior notes issued by two of our 100%
owned finance subsidiaries, Bunge Limited Finance Corp. and Bunge Finance
Europe B.V. There are largely no restrictions on the ability of Bunge Limited
Finance Corp. and Bunge Finance Europe B.V. or any other Bunge subsidiary to
transfer funds to Bunge Limited.

Contractual Obligations
The following table summarizes our scheduled contractual obligations and their
expected maturities at December 31, 2020, and the effect such obligations are
expected to have on our liquidity and cash flows in the future periods
indicated.
                                                                            

Payments due by period


                                                                                                                                    2026 and
(US$ in millions)                                   Total             2021             2022 - 2023           2024 - 2025           thereafter
Short-term debt                                  $  2,828          $  2,828          $          -          $          -          $          -
Long-term debt(1)                                   4,387                13                 1,497                 1,584                 1,293
Variable interest rate obligations                     15                 6                     7                     2                     -
Interest obligations on fixed rate debt               484               120                   198                   112                    54
Non-cancelable lease obligations(2)                   925               261                   365                   168                   131
Capital commitments                                    51                51                     -                     -                     -
Freight supply agreements(3)                          101               101                     -                     -                     -
Inventory purchase commitments                        641               628                    13                     -                     -
Power supply purchase commitments                      82                32                    22                    17                    11
Other commitments and obligations(4)                  136                53                    57                    23                     3
Total contractual cash obligations(5)            $  9,650          $  4,093          $      2,159          $      1,906          $      1,492




(1)Excludes components of long-term debt attributable to fair value hedge
accounting of $92 million and deferred financing fees and unamortized premiums
of $19 million.
(2)Represents future minimum payments under non-cancelable leases with initial
terms of one year or more. Minimum lease payments have not been reduced by
minimum sublease income receipts of $23 million due in future periods under
non-cancelable subleases.
(3)Represents purchase commitments for time on ocean freight vessels and
railroad freight lines for the purpose of transporting agricultural commodities.
The ocean freight service agreements are short term contracts with a duration of
less than a year. Ocean freight service agreements with terms in excess of one
year are included in non-cancelable lease obligations. The railroad freight
service agreements require a minimum monthly payment regardless of the actual
level of freight services used. The costs of our freight supply agreements are
typically passed through to our customers as a component of the prices we charge
for our products. However, changes in the market value of such freight services
compared to the rates at which we have contracted them may affect margins on the
sales of agricultural commodities.
(4)Represents other purchase commitments and obligations, such as take-or-pay
contracts, throughput contracts, and debt commitment fees.
(5)Does not include estimated payments of liabilities associated with uncertain
income tax positions. As of December 31, 2020, Bunge had uncertain income tax
liabilities of $52 million, including interest and penalties. At this time, we
are unable to make a reasonably reliable estimate of the timing of payments in
individual years in connection with these tax liabilities; therefore, such
amounts are not included in the above contractual obligations table. See Note
14- Income Taxes to our consolidated financial statements.
                                       49

--------------------------------------------------------------------------------

Table of Contents



Employee Benefit Plans
We expect to contribute $21 million to our defined benefit pension plans and $4
million to our postretirement benefit plans in 2021.

Critical Accounting Policies and Estimates
Our accounting policies are more fully described in Note 1- Nature of Business,
Basis of Presentation and Significant Accounting Policies to our consolidated
financial statements included as part of this Annual Report on Form 10-K. As
disclosed in Note 1, the preparation of financial statements in conformity with
U.S. GAAP requires management to make substantial judgment or estimation in
their application that may significantly affect reported amounts in the
financial statements and accompanying notes. Actual results could differ
significantly from those estimates. We believe the following discussion
addresses our most critical accounting policies, which are those that are most
important to the portrayal of our financial condition and results of operations
and require management's most difficult, subjective and complex judgments.
Offsetting
In the normal course of its operations we routinely enter into transactions
resulting in the recognition of assets and liabilities stemming from
unconditional obligations, for example trade receivables and trade payables, or
conditional obligations, for example unrealized gains and losses on derivative
contracts at fair value, with the same counterparty. We generally record all
such assets and liabilities on a gross basis, even when they are subject to
master netting agreements.
However, we also engage in various trade structured finance activities to
leverage the value of our global trade flows. These activities include programs
under which we generally obtain U.S. dollar-denominated letters of credit
("LCs"), each based on an underlying commodity trade flow, from financial
institutions and time deposits denominated in either the local currency of the
financial institutions' counterparties or in U.S. dollars, as well as foreign
exchange forward contracts, and other programs in which trade related payables
are set-off against receivables when all related assets and liabilities are
subject to legally enforceable set-off agreements and the criteria of ASC
210-20, Offsetting, has been met. Cash inflows are offset by the related cash
outflows resulting from placement of the time deposits and repayment of the LCs.
All cash flows related to the programs are included in operating activities in
the consolidated statements of cash flows.
Translation of Foreign Currency Financial Statements
Our reporting currency is the U.S. dollar. The functional currency of the
majority of our foreign subsidiaries is their local currency. As such, amounts
included in the consolidated statements of income, comprehensive income (loss),
cash flows, and changes in equity are translated using average exchange rates
during each period. Assets and liabilities are translated at period-end exchange
rates and resulting foreign currency translation adjustments are recorded in the
consolidated balance sheets as a component of accumulated other comprehensive
income (loss). However, in accordance with U.S. GAAP, if a foreign entity's
economy is determined to be highly inflationary, then such foreign entity's
financial statements are remeasured as if the functional currency were the
reporting currency.
  We have significant operations in Argentina and, up until June 30, 2018, had
utilized the official exchange rate of the Argentine peso published by the
Argentine government when recording applicable transactions and remeasuring
applicable assets and liabilities in its financial statements. Argentina has
experienced negative economic trends, as evidenced by multiple periods of
increasing inflation rates, devaluation of the peso, and increasing borrowing
rates, requiring the Argentine government to take mitigating actions. During the
second quarter of 2018, it was determined that Argentina's economy should be
considered highly inflationary, and as such, beginning on July 1, 2018, our
Argentine subsidiaries changed their functional currency to the U.S. Dollar.
This change in functional currency did not have a material impact on our
consolidated financial statements.
Foreign Currency Transactions
Monetary assets and liabilities denominated in currencies other than the
functional currency are remeasured into their respective functional currencies
at exchange rates in effect at the balance sheet date. The resulting exchange
gain or loss is included in our consolidated statements of income as Foreign
exchange gain (loss) unless the remeasurement gain or loss relates to an
intercompany transaction that is of a long-term investment nature and for which
settlement is not planned or anticipated in the foreseeable future. Gains or
losses arising from remeasurement of such transactions are reported as a
component of Accumulated other comprehensive income (loss) in our consolidated
balance sheets.
                                       50

--------------------------------------------------------------------------------

Table of Contents



Inventories and Derivatives
Our RMI, forward RMI purchase and sale contracts, and exchange traded futures
and options are primarily valued at fair value. RMI are freely-traded, have
quoted market prices, may be sold without significant additional processing and
have predictable and insignificant disposal costs. We estimate fair values of
commodity inventories and forward purchase and sale contracts on these
inventories based on commodity futures exchange quotations, broker or dealer
quotations, or market transactions in either listed or over-the-counter ("OTC")
markets with appropriate adjustments for differences in local markets where our
inventories are located. Certain inventories may utilize significant
unobservable data related to local market adjustments to determine fair value.
The significant unobservable inputs for RMI and physically settled forward
purchase and sale contracts relate to certain management estimations regarding
costs of transportation and other local market or location-related adjustments,
primarily freight related adjustments in the interior of Brazil and the lack of
market corroborated information in Canada. In both situations, we use
proprietary information such as purchase and sale contracts and contracted
prices to value freight, premiums, and discounts in our contracts. Changes in
the fair values of these inventories and contracts are recognized in our
consolidated statements of income as a component of Cost of goods sold. If we
used different methods or factors to estimate fair values, amounts reported as
Inventories and unrealized gains and losses on derivative contracts in the
consolidated balance sheets and Cost of goods sold in the consolidated
statements of income, respectively, could differ. Additionally, if market
conditions change subsequent to year-end, amounts reported in future periods as
Inventories, Unrealized gains and losses on derivative contracts, and Cost of
goods sold could differ.
Allowances for Uncollectible Accounts
Trade Accounts Receivable-Trade accounts receivable is stated at historical
carrying amounts net of write-offs and allowances for uncollectible accounts. We
establish allowances for uncollectible trade accounts receivable based on
lifetime expected credit losses utilizing an aging schedule for each pool of
trade accounts receivable. Pools are determined based on risk characteristics
such as the type of customer and geography. A default rate is derived using a
provision matrix with data based on Bunge's historical receivables information.
The default rate is then applied to the pool to determine the allowance for
expected credit losses. Given the short term nature of our trade accounts
receivable, the default rate is only adjusted if significant changes in the
credit profile of the portfolio are identified (e.g., poor crop years, credit
issues at the country level, systematic risk), resulting in historic loss rates
that are not representative of forecasted losses. Uncollectible accounts are
written off when a settlement is reached for an amount that is less than the
outstanding historical balance or when we have determined that collection of the
balance is unlikely.
Specifically, in establishing appropriate default rates as of December 31, 2020,
we took into consideration expected impacts on our customers and other debtors
in view of the COVID-19 pandemic, as well as other factors, which did not result
in a material impact on our financial statements.
We record and report accrued interest receivable within the same line item as
the related receivable. The allowance for expected credit losses is estimated on
the amortized cost basis of the trade accounts receivable, including accrued
interest receivable. We recognize credit loss expense when establishing an
allowance for accrued interest receivable.
Secured Advances to Suppliers-Secured advances to suppliers is stated at
historical carrying amounts net of write-offs and allowances for uncollectible
accounts. Secured advances to suppliers are expected to be settled through
delivery of non-cash assets and as such, allowances are established when
collection is not probable. We establish an allowance for secured advances to
suppliers, generally farmers and resellers of grain, based on historical
experience, farming economics and other market conditions as well as specific
customer collection issues. Uncollectible accounts are written off when a
settlement is reached for an amount below the outstanding historical balance or
when we have determined that collection is unlikely.
Secured advances to suppliers bear interest at contractual rates that reflect
current market interest rates at the time of the transaction. There are no
deferred fees or costs associated with these receivables. As a result, there are
no imputed interest amounts to be amortized under the interest method. Interest
income is calculated based on the terms of the individual agreements and is
recognized on an accrual basis.
We follow accounting guidance on the disclosure of the credit quality of
financing receivables and the allowance for credit losses, which requires
information to be disclosed at disaggregated levels, defined as portfolio
segments and classes. Under this guidance, secured advances to suppliers are
considered impaired, based on current information and events, if we determine it
probable that all amounts due under the original terms of the receivable will
not be collected. Recognition of interest income is suspended once the borrower
defaults on the originally scheduled delivery of agricultural commodities as the
collection of future income is determined not to be probable. No additional
interest income is accrued from the point of default until ultimate recovery, at
which time amounts collected are credited first against the receivable and then
to any unrecognized interest income.
                                       51

--------------------------------------------------------------------------------

Table of Contents

Goodwill


When we acquire a business, the consideration is first assigned to identifiable
assets and liabilities, including intangible assets, based on estimated fair
values, with any excess recorded as goodwill. Determining fair value requires
significant estimates and assumptions based on an evaluation of a number of
factors, including market participants, projected growth rates, the amounts and
timing of future cash flows, and the discount rates applied to the cash
flows. Determining the useful life of an asset also requires significant
judgment.
Our goodwill balance is not amortized to expense. Instead, it is tested for
impairment at least annually. We generally perform our annual impairment
analysis during the fourth quarter. If events or indicators of impairment occur
between annual impairment analyses, we perform an impairment analysis at that
date. These events or circumstances could include a significant change in the
business climate, legal factors, operating performance indicators, competition,
or sale or disposition of a significant asset. In testing for a potential
impairment of goodwill, we: (1) determine our reporting units; (2) allocate
goodwill to our various reporting units to which the acquired goodwill relates;
(3) determine the carrying value, or book value, of our reporting units; (4)
estimate the fair value of each reporting unit using a discounted cash flow
model and/or using market multiples; (5) compare the fair value of each
reporting unit to its carrying value; and (6) if the estimated fair value of a
reporting unit is less than the carrying value, we recognize an impairment
charge for such amount, but not exceeding the total amount of goodwill allocated
to that reporting unit.
The process of evaluating the potential impairment of goodwill is subjective and
requires significant judgment at many points during the analysis, including the
identification of our reporting units, identification and allocation of the
assets and liabilities to each of our reporting units, and determination of fair
value. In estimating the fair value of a reporting unit for the purposes of our
annual or periodic impairment analysis, we make estimates and significant
judgments about the future cash flows of that reporting unit aligned with
management's strategic business plans. Changes in judgment related to these
assumptions and estimates could result in goodwill impairment charges. We
believe the assumptions and estimates used are appropriate based on the
information currently available to management. Estimates based on market
earnings multiples of peer companies identified for the reporting unit may also
be used, where available. Critical estimates in the determination of fair value
under the income approach include, but are not limited to, assumptions about
variables such as commodity prices, crop throughput and production volumes,
profitability, future capital expenditures and discount rates, all of which are
subject to a high degree of judgment.
During the fourth quarter of 2020, we performed our annual impairment assessment
and determined the estimated fair values of each of our goodwill reporting units
exceeded each of their carrying values. See Note 8- Goodwill, to our
consolidated financial statements. During the fourth quarter of 2019, we
recorded a goodwill impairment charge of $108 million related to what had been
our Bunge Loders Croklaan reporting unit.
Property, Plant and Equipment and Other Finite-Lived Intangible Assets
Long-lived assets include property, plant and equipment and other finite-lived
intangible assets. Property, plant and equipment and finite-lived intangible
assets are depreciated or amortized over their estimated useful life on a
straight line basis. When facts and circumstances indicate the carrying values
of these assets may be impaired, an evaluation of recoverability is performed by
comparing the carrying value of the assets to the undiscounted projected future
cash flows to be generated by such assets from their use and ultimate disposal.
If it appears the carrying value of our assets is not recoverable, we compare
the carrying value of the assets to the discounted projected future cash flows
to be generated by such assets from their use and ultimate disposal, and if the
carrying value is greater, recognize an impairment loss for the difference
between the discounted projected future cash flows and the carrying value of the
assets as a charge against results of operations. Our judgments related to the
expected useful lives of these assets and our ability to realize undiscounted
cash flows in excess of the carrying amount of such assets are affected by
factors such as the ongoing maintenance of the assets, changes in economic
conditions and changes in operating performance. As we assess the ongoing
expected cash flows and carrying amounts of these assets, changes in these
factors could cause us to realize material impairment charges. We recorded
impairment charges of $180 million for property, plant and equipment and
intangible assets during the year ended December 31, 2019, primarily related to
portfolio rationalization initiatives.
Contingencies
We are a party to a large number of claims and lawsuits, primarily non-income
tax and labor claims in Brazil and non-income tax claims in Argentina, and we
make provisions for potential liabilities arising from such claims when we deem
them probable and reasonably estimable. These estimates of probable loss have
been developed in consultation with in-house and outside counsel and are based
on an analysis of potential results, assuming a combination of litigation and
settlement strategies. Future results of operations for any particular quarterly
or annual period could be materially affected by changes in our assumptions or
the effectiveness of our strategies relating to these proceedings. For more
information on tax and labor claims in Brazil, see "Item 3. Legal Proceedings"
                                       52

--------------------------------------------------------------------------------

Table of Contents



Income Taxes
We record valuation allowances to reduce our deferred tax assets to the amount
that we are likely to realize. We consider projections of future taxable income
and prudent tax planning strategies to assess the need for and the amount of the
valuation allowances. If we determine that we can realize a deferred tax asset
in excess of our net recorded amount, we decrease the valuation allowance,
thereby decreasing income tax expense. Conversely, if we determine that we are
unable to realize all or part of our net deferred tax asset, we increase the
valuation allowance, thereby increasing income tax expense.
We apply a "more likely than not" threshold to the recognition and
de-recognition of tax benefits. Accordingly, we recognize the amount of tax
benefit that has a greater than 50 percent likelihood of being ultimately
realized upon settlement. The calculation of our uncertain tax positions
involves complexities in the application of intricate tax regulations in a
multitude of jurisdictions across our global operations. Future changes in
judgment related to the ultimate resolution of unrecognized tax benefits will
affect the earnings in the quarter of such change. At December 31, 2020 and
2019, we had recorded uncertain tax positions of $52 million and $53 million,
respectively, in our consolidated balance sheets. For additional information on
income taxes, please refer to Note 14- Income Taxes to our consolidated
financial statements included as part of this Annual Report on Form 10-K.
Recoverable Taxes
We evaluate the collectability of our recoverable taxes and record allowances if
we determine that collection is doubtful. Recoverable taxes include value-added
taxes paid upon the acquisition of property, plant and equipment, raw materials
and taxable services and other transactional taxes, which can be recovered in
cash or as compensation against income taxes, or other taxes we may owe,
primarily in Brazil and Europe. Management's assumption about the collectability
of recoverable taxes requires significant judgment because it involves an
assessment of the ability and willingness of the applicable federal or local
government to refund the taxes. The balance of these allowances fluctuates
depending on the sales activity of existing inventories, purchases of new
inventories, percentages of export sales, seasonality, changes in applicable tax
rates, cash payments by the applicable government agencies and the offset of
outstanding balances against income or certain other taxes owed to the
applicable governments, where permissible. At December 31, 2020 and 2019, the
allowance for recoverable taxes was $58 million and $78 million, respectively.
We continue to monitor the economic environment and events taking place in the
applicable countries and in cases where we determine that recovery is doubtful,
recoverable taxes are reduced by allowances for the estimated unrecoverable
amounts.
New Accounting Pronouncements
See Note 1- Nature of Business, Basis of Presentation and Significant Accounting
Policies to our consolidated financial statements included as part of this
Annual Report on Form 10-K.

© Edgar Online, source Glimpses